These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29627994)

  • 21. Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review.
    Bruckert E; Parhofer KG; Gonzalez-Juanatey JR; Nordestgaard B; Arca M; Giovas P; Ray K
    Adv Ther; 2020 May; 37(5):1724-1736. PubMed ID: 32200537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus.
    Li L; Ambegaonkar BM; Reckless JP; Jick S
    Eur J Prev Cardiol; 2014 Jul; 21(7):855-65. PubMed ID: 23460659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.
    Ouyang XJ; Zhang YQ; Chen JH; Li T; Lu TT; Bian RW
    Chin Med J (Engl); 2018 Feb; 131(3):295-300. PubMed ID: 29363644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study.
    Danese MD; Gleeson M; Kutikova L; Griffiths RI; Khunti K; Seshasai SRK; Ray KK
    BMJ Open; 2017 May; 7(5):e013851. PubMed ID: 28495810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
    Wan EYF; Xu W; Mok AHY; Chin WY; Yu EYT; Chui CSL; Chan EWY; Wong ICK; Lam CLK; Danaei G
    Diabetes Obes Metab; 2024 May; 26(5):1877-1887. PubMed ID: 38379445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.
    Journath G; Hambraeus K; Hagström E; Pettersson B; Löthgren M
    BMC Cardiovasc Disord; 2017 Aug; 17(1):224. PubMed ID: 28814290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
    Rahman Al-Nuaim A
    Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic.
    Schatz U; Fischer S; Müller G; Tselmin S; Birkenfeld AL; Julius U; März W; Bornstein SR
    Atheroscler Suppl; 2019 Dec; 40():94-99. PubMed ID: 31818455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T; Uno K; Miyoshi I; Khan I; Gorcyca K; Sanchez RJ; Yoshida S; Mawatari K; Masaki T; Arai H; Yamashita S
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
    Soubrier M; Zerkak D; Dougados M
    J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.